• Deutsch (DE-CH-AT)
  • English (United Kingdom)

NOTICE

with regard to the manufacturing license:
TICEBA
possesses the required authorization by the competent authority for the manufacturing of tissue as source material of human origin for the manufacturing of pharmaceuticals in accordance with § 20 b and § 20 c of the German Medicines Act: Authorization for the treatment or processing, preservation, storage of tissue or tissue preparations.

Current possibilities of application


In all fields of medicine, uses for stem cells are being researched or even today being used clinically as treatment attempt in order to heal defective tissues or grow replacement tissue.


Current fields of application

In cardiology, stem cell therapy following heart attacks has already entered daily routine.
The growth or reproduction of skin cells and chondrocytes has become a routine procedure in medicine today in order to cover major skin or cartilage defects in the area of joints.
In laboratory conditions, kidney cells were manufactured using the tissue engineering and their functionality has been proven. Other spare organs or parts are also already being grown in laboratory conditions and used experimentally in animal experiments.


NEWS

TICEBA receives SME eligibility of EMA. continue »
TICEBA now on facebook. continue »
next event:
29. - 31. May 2012, ECOPRAM - European Congress on Preventive, Regenerative and Anti-Aging Medicine, Istanbul (Turkey). Topic: "Autologous pluripotent mesenchymal stem cells from the skin". Booth: 12. continue »

NEWSLETTER

INFORMATIONS

Request any information from us now.

COUNSELLING

"We are glad to counsel you in person", Dr. Christoph Ganss:
+49 (0)6221.718 33 0